Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine
- 1 May 2003
- Vol. 21 (17-18) , 2207-2217
- https://doi.org/10.1016/s0264-410x(03)00029-x